20 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Studio randomizzato

Testing the EQ-HWB-9 with seven-day versus today recall periods in dementia: variability and recall adherence under health fluctuations.

Maresa Buchholz, Lidia Engel, Feng Xie, Bernhard Michalowsky

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026

Abstract originale

PURPOSE: To compare a "7-DAY" and "TODAY" recall period of the EQ-HWB-9 in people living with dementia (PlwD) with regard to day-to-day health changes (health fluctuations) and recall period adherence. METHODS: In this mixed-methods study, PlwD-caregiver dyads from German primary care were randomized to complete the EQ-HWB-9 (self- and proxy-proxy report) using either a "7-day" or "today" recall period over a two-week time period on day 1, day seven and day 14. In addition, caregivers recorded daily health fluctuations over 14 days via a diary. Health fluctuations were examined in relation to EQ-HWB-9 score variability and recall adherence, which was assessed via semi-structured caregiver interviews. Quantitative analyses included recall group comparisons, effect sizes, and variance analyses. RESULTS: Seventy-four dyads were included (PlwD mean age 77 years; 41.9% female; caregiver mean age 71 years; 71.6% female). Proxy EQ-HWB-9 scores were higher (worse health) than self-reports and higher with the "7-day" versus "today" recall. Caregivers reported at least one health fluctuation in 92% of PlwD; fluctuations occurred in 41% of daily assessments. Greater diary-documented fluctuation was associated with higher EQ-HWB-9 score variability. Recall adherence differed by health fluctuation status: caregivers of PlwD with no to low health fluctuations favored TODAY, whereas those of PlwD with high health fluctuations favored the 7-DAY recall time frame. CONCLUSIONS: No single recall period appears optimal for all PlwD. Recall period selection should consider individual health fluctuation patterns to improve the performance of HRQoL assessments in dementia.

Parole chiave

HumansDementiaFemaleAgedMental RecallCaregiversMaleQuality of LifeAged, 80 and overGermanySurveys and QuestionnairesPsychometricsHealth StatusMiddle AgedSelf ReportTime FactorsEQ-HWBHealth fluctuationHealth-related quality of lifePatient-reported outcome measuresRecall periods
Leggi il testo integrale originale

Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.

Testing the EQ-HWB-9 with seven-day versus today recall periods in dementia: variability and recall adherence under health fluctuations

Purpose

To compare a “7-DAY” and “TODAY” recall period of the EQ-HWB-9 in people living with dementia (PlwD) with regard to day-to-day health changes (health fluctuations) and recall period adherence.

Methods

In this mixed-methods study, PlwD-caregiver dyads from German primary care were randomized to complete the EQ-HWB-9 (self- and proxy-proxy report) using either a "7-day" or “today” recall period over a two-week time period on day 1, day seven and day 14. In addition, caregivers recorded daily health fluctuations over 14 days via a diary. Health fluctuations were examined in relation to EQ-HWB-9 score variability and recall adherence, which was assessed via semi-structured caregiver interviews. Quantitative analyses included recall group comparisons, effect sizes, and variance analyses.

Results

Seventy-four dyads were included (PlwD mean age 77 years; 41.9% female; caregiver mean age 71 years; 71.6% female). Proxy EQ-HWB-9 scores were higher (worse health) than self-reports and higher with the "7-day" versus “today” recall. Caregivers reported at least one health fluctuation in 92% of PlwD; fluctuations occurred in 41% of daily assessments. Greater diary-documented fluctuation was associated with higher EQ-HWB-9 score variability. Recall adherence differed by health fluctuation status: caregivers of PlwD with no to low health fluctuations favored TODAY, whereas those of PlwD with high health fluctuations favored the 7-DAY recall time frame.

Conclusions

No single recall period appears optimal for all PlwD. Recall period selection should consider individual health fluctuation patterns to improve the performance of HRQoL assessments in dementia.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s11136-026-04432-4.

Plain Language summary

People living with dementia (PlwD) often experience recurrent, often unpredictable, day-to-day changes in their health, with some days better (e.g. better memory), others worse (e.g. aggressive behaviour), so-called health fluctuations. Measuring the quality of life in PlwD has become an essential goal in the treatment and research of dementia. Nevertheless, it is unknown how quality-of-life questionnaires can capture these day-to-day changes in PlwD across different recall periods. In our study, we compared a "7-day" recall period with a “today” recall period using the EQ-HWB-9 questionnaire, an instrument of health and well-being. PlwD and their caregivers completed the questionnaire over 2 weeks, on days 1, 7, and 14. At the same time, caregivers kept a daily diary documenting whether the PlwD’s health had improved, worsened, or stayed the same compared to the previous day. We found that health fluctuations were very common: caregivers reported to perceive at least one change in most of PlwD, which are often related to exhaustion, depression and cognitive changes. We also found that caregivers who document no to low health fluctuations are more likely to use the today recall period than those who report greater day-to-day changes in PlwD. These caregivers often adhere to the 7-day recall time frame. We conclude that the choice of recall periods matters. In conditions like dementia, where health can change frequently, selecting an appropriate recall period is essential for accurately capturing quality of life.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s11136-026-04432-4.

Introduction

Degenerative diseases rarely follow a steady, linear disease progression. Instead, individuals with chronic conditions often experience recurrent and unpredictable day-to-day changes in their health, commonly referred to as health fluctuations [1–3]. People living with dementia (PlwD) are some of those who frequently describe alternating periods of “better” and “worse” days, marked by enhanced cognition, motivation, and activity on good days and memory decline, irritability, or behavioural disturbances on bad days [4]. Cognitive variability has been examined in clinical studies [5, 6], emphasizing that cognitive fluctuations remain one of the most complex and least understood symptoms in dementia. Sun et al. [7] found that cognitive variability was associated with reduced capacity for daily activities and diminished health-related quality of life (HRQoL), underscoring the importance of considering short-term fluctuations in HRQoL research [4].

Prior studies have identified a recurring challenge in the use of generic preference-based HRQoL instruments, where respondents often fail to adhere to the intended recall periods and prefer various recall time frames due to their health condition [8]. This was particularly evident in the EQ-5D, which asks about “your health today” (Recall period “Today”) [9]. Although the EQ-5D is valid for use among individuals with moderate cognitive and functional impairment [10–13], its one-day recall time frame may not adequately reflect the overall health experience of patients who face frequent daily changes, thereby affecting both the validity and the reliability of responses. This was supported by a recent study by Michalowsky et al. [14], demonstrating that PlwD frequently experienced health fluctuations, on average, every second day. These fluctuations were primarily triggered by issues with memory, mobility, concentration, sleep, pain, and usual activities, affecting the HRQoL assessment using the EQ-5D-5​L and resulting in a higher variation in EQ-5D-5​L utility and non-adherence to the recall period. This warranted further research to evaluate whether extended recall periods could capture health fluctuations more accurately. Moreover, there is limited clarity on which specific dimensions are most influenced by symptom fluctuations, especially when considering broader constructs of wellbeing that go beyond health. The EQ Health and Well-being (EQ-HWB) is a new measure, specifically designed to be applicable across health and social care settings, reflecting aspects of life relevant to people with long-term and complex conditions. Importantly, the EQ-HWB uses a “7-day” recall period, which may enhance its ability to represent overall health in individuals experiencing recurrent symptom fluctuations, such as those living with dementia. This extended recall frame, alongside its multidimensional scope, may result in more valid and reliable assessments of HRQoL in populations affected by daily variability.

However, evidence about whether the EQ-HWB captures health state fluctuations different to those measures with a “Today” recall period is currently lacking. Therefore, this study aimed to close these gaps by using a daily health fluctuation diary and administering the EQ-HWB-9 questionnaire with its original “7-DAY” versus an experimental “TODAY” recall period, evaluating the variability of both recall periods, and recall period adherence.

Methods

Study design

This exploratory, observational study employed a mixed-methods approach to investigate (i) the day-to-day variability in HRQoL, as documented by informal caregivers (hereinafter referred to as “caregivers”) and PlwD (dyads) using a daily paper-based diary across 14 days, and (ii) the influence of these fluctuations on score variability and (iii) recall-period adherence when assessing HRQoL through the EQ-HWB-9 across two randomly assigned groups (based on dyads of PlwD and their caregivers) where the EQ-HWB-9 was administered with the original “7-DAY” recall period (GROUP 1) and an experimental recall period of “TODAY” (GROUP 2). Randomization was performed using a pre-defined allocation sequence to ensure an equal distribution of participant across both groups (1:1).

The EQ-HWB-9 questionnaires were administered as a self- (by PlwD) and proxy-proxy version (by caregivers) (1st) on day 1, after starting the daily health fluctuation diary, (2nd) on day 7, and (3rd) on day 14, after completing the daily health fluctuation diary (see Fig. 1). Caregivers provided proxy-proxy ratings reflecting their own perception of the PlwD’s health and wellbeing, rather than proxy-person ratings estimating how patients would rate themselves [9]. The assigned recall period was specified for each EQ-HWB-9 domain. PlwD and caregivers were interviewed one after the other by the trained study nurse, without the other person being present. Finally, the caregivers were interviewed immediately after completing the daily diary and the last EQ-HWB-9 administration, using semi-structured interviews to determine whether they adhered to the given recall periods of “7 DAYS” (GROUP 1) or “TODAY” (GROUP 2).

The study design is demonstrated in Fig. 1.

Setting and sample

Participant dyads, consisting of PlwD and their caregivers, were recruited from German primary care settings between May 2023 and December 2024. Recruitment was conducted through trained study nurses. Eligibility required a positive dementia screening using the DemTect tool (score ≤ 8) [15] or a formal dementia diagnosis by a treating physician (GP, neurologist, or psychiatrist). Caregivers were eligible if they lived with the PlwD together or visited the PlwD daily. Eligible participants were given study information and asked to provide written informed consent. Ethical approval was obtained from the local ethics committee at the University Medicine Greifswald (reference number BB 030/23).

Given the exploratory nature of the study, no formal sample size calculation was conducted. The sample size was informed by a previous study [14] in a similar population.

Data assessment

The baseline and follow-up surveys were conducted via face-to-face interviews with the PlwD and the caregivers at the dyads’ homes. The paper-pencil diary was daily self-completed by caregivers.

Demographic and clinical data

PlwD’ demographic, including age, sex, living situation (alone vs. not alone) and the following clinical variables were assessed at baseline: cognitive impairment according to the Mini-Mental State Examination (MMSE) [16, 17], depression according to the Geriatric Depression Scale (GDS) [18], deficits in daily living activities according to the Bayer Activities of Daily Living Scale (B-ADL), comorbidity according to the Charlson Comorbidity Index (CCI) [19] and caregiver burden by the Zarit Burden Interview [20].

EQ-HWB-9

The EQ-HWB-9, a measure of health and well-being with a 7-day recall period, was explicitly developed for caregivers and care recipients to evaluate interventions in health, public health, and social care, including their impact on patients, social care users, and caregivers. The EQ-HWB was recently evaluated in caregivers of PlwD, demonstrating sufficient psychometric properties [21]. The EQ-HWB-9 (formerly EQ-HWB-S) is a concise, short-form instrument derived from the 25-item EQ-HWB [10], covering the following nine dimensions: mobility, daily activity, exhaustion, loneliness, cognition, anxiety, sadness/depression, control, and pain. Each domain has one question with five response-level options [22] (Supplementary File 1). At present, there is no German value set for the EQ-HWB-9. Therefore, in line with previous research, we used the level sum scores (LSS) of the EQ-HWB-9, ranging from 9 (best health/well-being) to 45 (worst health/well-being) [23]. To minimize respondent burden, the selection of the EQ-HWB-9 was guided by its brevity.

Health fluctuation diary

After completing the baseline assessment, caregivers were introduced to the health fluctuation diary and asked to complete it daily for 14 days. A health state fluctuation was defined as any perceived day-to-day change in the PlwD’s overall health compared to the previous day, as judged from the caregiver’s perspective. Caregivers rated the PlwD’s health as (i) much better, (ii) somewhat better, (iii) about the same, (iv) somewhat worse, or (v) much worse (see ​Fig. 1). On day seven, the study nurse reviewed diary entries, provided further assistance to minimize entry errors.

Health fluctuations documented in the daily diary were operationalized in two ways: (i) dichotomously, indicating whether at least one fluctuation was reported during the 14-day period, and (ii) by the total number of fluctuations recorded over 14 days, categorized as no to low (0–5) or moderate to high (> 5) fluctuations.

Qualitative semi-structured interview data

After completing the diary and the EQ-HWB-9 on day 14, the study nurse conducted a semi-structured interview with the caregiver, asking about the documented fluctuations and whether these fluctuations were considered in assessing the PlwDs health and well-being using the original “7-DAY” (GROUP 1) or the experimental “TODAY” (GROUP 2) recall period. Caregivers were also asked if they adhered to the respective recall period (today or 7-day) when responding to the EQ-HWB-9.

An interview guide was used, and the study nurses were trained to ensure the replicability of interviews (Supplementary File 2).

Analyses

Only complete cases were analyzed without imputing missing data. Descriptive statistics were used to describe respondents’ characteristics, health state fluctuations and health changes based on the fluctuation diary and the EQ-HWB-9 Level Sum Scores (LSS). Differences between groups were assessed using ANOVA and Chi2 tests. Spearman correlations (rsp) were calculated to examine the relationship between self- and proxy-reported LSS at each assessment time point, stratified by recall period.

Based on the LSS, both recall period versions were analyzed descriptively and in terms of variability (variance of the LSS mean change, s2), considering documented health fluctuations from the daily diary entries (no to low fluctuation: 0–5 fluctuations in 14 days, moderate to high fluctuation: more than five fluctuations in 14 days). An absolute mean change ≤ 1 of LSS was considered indicative of low variability, representing a small change relative to the EQ-HWB-9 scale range. Given previous findings demonstrating that greater health fluctuations in PlwD were associated with increased variability in EQ-5D-5 L reports [14], we hypothesized that PlwD with more health fluctuations would show greater EQ-HWB-9 score variability with the today recall than those with low fluctuations using the 7-day recall period. All statistical analyses were carried out using the statistical program STATA 18.

Qualitative analysis of recall period adherence

Recall-period adherence was assessed by asking caregivers in the interview whether they had followed the assigned temporal frame (TODAY or 7-DAY) when completing the EQ-HWB-9. This explored whether caregivers understood and applied the intended time period when evaluating the PlwD’s health and wellbeing. This information also provides context for interpreting EQ-HWB-9 results, as deviations from the assigned recall period may affect the health experiences considered when responding to the measure. We dichotomously coded responses (yes/no) and analysed them descriptively by fluctuation frequency. We assessed differences between groups using Fisher’s exact tests and across fluctuation groups using the Chi-squared test. In addition, deviations from the assigned recall period were documented and caregivers were asked what time frame they had considered.

Results

Sample characteristics

Seventy-four dyads were included. The sample characteristics are shown in Table 1. PlwD were, on average, 77 years old, primarily male (58%), and moderately cognitively (mean MMST: 18.1) and functionally (mean B-ADL: 6.7) impaired. The two study groups were generally comparable (p > 0.05) with regard to demographic (age, gender) and clinical characteristics (MMSE, CCI) at baseline. A statistically significant difference was only observed for B-ADL.

Table 1Patients’ socio-demographic and clinical characteristics and patients’ health-related quality of life at baseline (day 1)

Overall(n = 74)

Sociodemographics

Patient age (mean, SD) 77.3 (8.0)

Caregiver age (mean, SD) 70.6 (10.6)

Female sex patients (n, %) 31 (41.9%)

Female sex caregiver (n, %) 53 (71.6%)

Relationship

Partner/spouse (n, %) 58 (78.4%)

Living together (n, %) 69 (93.2%)

Clinical characteristics

Deficits in ADL (B-ADL) 6.7 (2.3)

Cognition (MMST) 18.1 (7.9)

Depression (GDS) 6.1 (2.1)

Caregiver burden (Zarit) 8.6 (4.8)

Comorbidity (Charlson) 4.0 (2.1)

EQ-HWB-9 scores

Recall period “7-DAY”

Patient self-rating LSS, mean (SD, var) 15.1 (4.9, 24.4)

Caregiver proxy-rating LSS, mean (SD, var) 21.5 (5.9, 34.3)

Recall period “TODAY”

Patient self-rating LSS, mean (SD, var) 14.3 (4.5, 20.1)

Caregiver proxy-rating LSS, mean (SD, var) 19.9 (6.2, 39.3)

n= number, SD: Standard Deviation, var: variance, B-ADL: Bayer Activities of Daily Living Scale; MMSE: Mini-Mental State Examination, GDS: Geriatric Depression Scale; Zarit: Caregiver Burden Zarit Interview, Comorbidity: Charlson Comorbidity Index.

Seven dyads had incomplete self- and proxy-reported EQ-HWB-9 data, with no notable demographic differences from complete cases. The mean EQ-HWB-9 self- and the proxy-reported LSS at baseline were 15.1 (SD 4.9, var 24.4) and 21.5 (5.9, 34.3) for the 7-DAY recall period, and 14.3 (4.5, 20.1) and 19.9 (6.2, 39.3) for the TODAY recall period, respectively. Proxy-ratings were higher than self-ratings, and the 7-DAY recall period also yielded higher scores compared to the TODAY recall period, indicating worse health estimates. Correlations between self- and proxy-reported EQ-HWB-9 LSS were weak to moderate across assessment time points. In the TODAY group, correlations ranged from rsp=0.36 to 0.45 (each p < 0.05), whereas in the 7-DAY group, correlations were weaker at day 1 (rsp=0.24), and day 7 (rsp=0.14) and moderate at day 14 (rsp=0.45, p < 0.05).

(Please insert Table 1 here.)

Health state fluctuations

In total, caregivers (n = 74) gave n = 908 daily assessments (n = 128 missing assessments; 12,4%). Of those, 92% reported at least one daily fluctuation; six caregivers (8%) never reported fluctuations. Caregivers documented health state fluctuations of PlwD in 41.0% of daily assessments (372 of 908), rating PlwDs’ today’s health as better (much: 1.9% or somewhat: 18.2%) or worse (much: 2.2% or somewhat: 18.2%) than the day before. Thirty-six caregivers documented up to five health fluctuations (group: “no to low fluctuation”, while 38 caregivers documented more than five fluctuations (group: moderate to high fluctuation). Health fluctuations are shown in Table 2.

Table 2Frequency of today’s health fluctuation (compared to yesterday) of n = 908 daily assessments from 74 caregivers of 74 patients with dementia

Today’s health compared to yesterday n (%)

Much better today 17 (1.87%)

Somewhat better today 170 (18.2%)

About the same today 536 (59.0%)

Somewhat worse today 165 (18.2%)

Much worse today 20 (2.2%)

Σ Fluctuations 372 (41.0%)

Σ No fluctuations 536 (59.0%)

Distribution of the number of health fluctuations n (%)

0 6 (8.11%)

1 4 (5.41%)

2 6 (8.11%)

3 4 (5.41%)

4 10 (13.51%)

5 6 (8.11%)

6 6 (8.11%)

7 12 (16.22%)

8 7 (9.46%)

9 5 (6.76%)

10 3 (4.05%)

11 4 (5.41%)

12 1 (1.35%)

n = 128 assessments were missing (1.73 assessments per caregiver)

Variability of EQ-HWB-9 dimension scores

Across days 1, 7, and 14, EQ-HWB-9 health states changed between assessments in 92.5% of PlwD self-ratings and 100% of proxy-ratings compared with the assessment seven days earlier. Proxy-rated health varied in all cases, irrespective of recall period. Self-ratings varied more frequently with the 7-DAY than with the “TODAY” recall (97.0% vs. 87.9%), however, this difference was not statistically significant (p = 0.355).

Across dimensions, exhaustion, sadness/depression, and cognition most frequently changed over time, regardless of perspective. When comparing recall periods at the dimension level, changes were generally more frequent with the 7-DAY recall (Table 3).

Table 3Description of the percentage change of the EQ-HWB-9 dimensions and profile between assessments (day 1 and day 7 or day 7 and day 14)

Recall period“7-DAYs” Recall period “TODAY” p-value1

EQ-HWB-9 patient self-rating n = 33 n = 33

Mobility 33.3% 51.5% 0.010

Daily activity 45.5% 51.5% 0.653

Exhaustion 75.8% 69.7% 0.990

Loneliness 39.4% 45.5% 0.804

Cognition 63.6% 60.6% 0.995

Anxiety 36.4% 30.3% 0.791

Sadness/depression 75.7% 69.7% 0.997

Control 42.4% 51.5% 0.366

Pain 45.5% 30.3% 0.271

Health state 97.0% 87.9% 0.355

EQ-HWB-9 caregiver proxy-rating n = 34 n = 34

Mobility 67.7% 58.8% 0.808

Daily activity 73.5% 38.2% 0.009

Exhaustion 82.3% 85.3% 0.754

Loneliness 47.1% 47.0% 0.818

Cognition 73.5% 79.4% 0.999

Anxiety 50.0% 47.1% 0.999

Sadness/depression 82.4% 85.3% 0.999

Control 61.8% 61.8% 0.999

Pain 50.0% 44.1% 0.490

Health state 100.0% 100.0% 0.999

Recall period adherence2 80% 87% 0.376

Bold indicates a higher percentage change within the respective recall period

1Fisher Exact test; 2 based on responses of caregivers given during the qualitative, semi-structured interview on day 14 after completing the EQ-5D-5 L., Classification of health fluctuations (frequency): 0–4 low; 5–9 moderate and 9–14 high; percentages and mean change include both self- and proxy responses combined

EQ-HWB-9 level sum score variation across health fluctuation

Greater diary-documented fluctuation was associated with increased variability in EQ-HWB-9 LSS (Table 4). PlwD with moderate to high fluctuations showed larger absolute changes and greater dispersion than those with no or low fluctuations. Across recall groups, the 7-DAY recall tended to show slightly lower median absolute changes compared with the “TODAY” recall (Table 4, Supplementary 3 Fig. 1). However, distributions overlapped substantially, and isolated extreme values in the 7-DAY group contributed to increased variance.

Table 4Description of patients and caregiver EQ-HWB-9 responses by fluctuation degree (No to low, moderate to high) across recall period groups (“7-DAY” vs. “TODAY”)

EQ-HWB-9 responses Overall No to lowfluctuation Moderate to high fluctuation

“7-DAY” Self-rating n = 33 n = 14 n = 19

LSS – day 1, mean (SD) 14.8 (5.6) 12.1 (3.17) 16.9 (6.10)

LSS – day 7, mean (SD) 15.5 (5.7) 12.7 (3.85) 17.6 (6.02)

LSS – day 14, mean (SD) 15.0 (5.2) 11.9 (2.98) 17.4 (5.29)

Absolute mean (SD) change1 2.75 (2.86) 1.75 (2.16) 3.50 (3.14)

Median (25%-75% percentiles) 2.0 (0.5-4.0) 1.0 (0.5-2.0) 2.3 (1.5–4.5)

Variance (skewness) of abs. change1 8.22 (1.86) 4.68 (1.54) 9.86 (1.82)

“TODAY” Self-rating n = 33 n = 18 n = 15

LSS – day 1 14.6 (4.9) 14.7 (5.47) 14.5 (4.39)

LSS – day 7 13.9 (4.8) 13.1 (3.92) 14.9 (5.87)

LSS – day 14 14.2 (5.4) 13.7 (6.02) 14.9 (4.74)

Absolute mean (SD) change1 2.86 (2.04) 2.64 (2.06) 3.13 (2.06)

Median (25%-75% percentiles) 3.0 (1.5-4.0) 3.0 (0.5–4.5) 3.0 (1.5-4.0)

Variance (skewness) of change1 4.19 (0.27) 4.26 (0.04) 4.27 (0.55)

F(df1,df2), p-value 1.96, 0.048 1.10, 0.370 2.31, 0.035

“7-Day” Proxy-rating n = 34 n = 15 n = 19

LSS – day 1 21.6 (6.2) 19.1 (6.09) 23.6 (5.68)

LSS – day 7 21.9 (6.1) 19.0 (5.80) 24.1 (5.54)

LSS – day 14 21.0 (6.1) 18.3 (6.56) 23.2 (4.79)

Absolute mean (SD) change1 2.60 (1.92) 2.23 (1.40) 2.90 (2.25)

Median (25%-75% percentiles) 2.5 (1.0-3.5) 2.5 (1.0–3.0) 2.5 (1.0–4.0)

Variance (skewness) of change1 3.72 (1.68) 1.96 (0.71) 5.10 (1.57)

“TODAY” Proxy-rating n = 33 n = 17 n = 17

LSS – day 1 20.7 (6.9) 19.6 (6.11) 21.6 (7.81)

LSS – day 7 20.4 (6.1) 19.8 (6.08) 20.35 (6.72)

LSS – day 14 19.5 (6.4) 18.0 (6.93) 20.29 (6.09)

Absolute mean (SD) change1 3.01 (2.08) 2.79 (1.57) 3.24 (2.52)

Median (25%-75% percentiles) 2.3 (1.5–4.5) 2.0 (2.0-3.5) 2.5 (1.5–4.5)

Variance (skewness) of change1 4.32 (1.00) 2.47 (0.82) 6.34 (0.81)

F(df1,df2), p-value 1.16, 0.290 1.26, 0.320 1.24, 0.270

1absolute mean change from day one to day seven and from day seven to day 14; Classification of health fluctuations (frequency): no to low, 0–5 fluctuations within 14 days documented in the diary by a caregiver; moderate to high, more than 5 fluctuations within 14 days; Analysis is based on complete data across all three assessment time points

Furthermore, the proportion of assessments with very low absolute change (≤ 1) was higher in the 7-DAY group (36.4% and 29.4%, respectively) than in the “TODAY” group (24.2% and 20.6%, respectively), particularly among PlwD with no or low health fluctuations (self-assessment: 7-DAY 64.3% vs. 33.5%; proxy-assessment: 7-DAY 33.3% vs. 17.7%) (Supplementary 3 Table 1).

Adherence to EQ-HWBs’ recall period ​

In total, 73 interviews were conducted; one caregiver was not able to give an interview. The recall period adherence was statistically significant higher in caregivers responding to the recall period of “TODAY” (86%) compared to those responding to the recall period of “7-DAYS” (76%).

For those assigned to the recall period of “7-DAYS”, the adherence was lowest among PlwD without or with low health fluctuations (73.3%), where most caregivers indicated in the interview that the recall period was too long and tended to consider shorter time frames when responding. However, for caregivers of PlwD with moderate to high health fluctuations, recall period adherence increased to 85.0% when using the “7-DAY” recall period. Contrary to this, caregivers responding to a recall period of “TODAY” had the highest recall period adherence in PlwD without or with low health fluctuations (95.0%), but a lower adherence in PlwD with moderate to high fluctuations (76.4%). In these cases, caregivers indicated that the recall period was too short and sometimes considered one or more preceding days, when completing the TODAY assessment. The recall period adherence is demonstrated in Table 5.

Table 5Number and percentage of patients adhering to the original (“7-DAY”) and experimental (“TODAY”) recall period of the EQ-HWB-9, overall and across fluctuation

Caregiver proxy-ratings Overall No to lowfluctuation1 Moderate to high fluctuation1

“7-DAY” recall period n = 35 n = 15 n = 20

Number (%) of patients adhering to the recall period 28 (80.0%) 11 (73.3%) 17 (85.0%)

“TODAY” recall period n = 37 n = 20 n = 17

Number (%) of patients adhering to the recall period 32 (86.5%) 19 (95.0%) 13 (76.4%)

Total sample n = 72 n = 35 n = 37

Number (%) of patients adhering to the recall period 60 (83.3%) 30 (85.7%) 30 (81.1%)

1absolute mean change from day one to day seven and from day seven to day 14; Classification of health fluctuations (frequency): no to low, 0–5 fluctuations within 14 days documented in the diary by a caregiver; moderate to high, more than five fluctuations within 14 days

Discussion

Summary of key findings

With this study, we evaluated the usability of a “7-DAY” vs. “TODAY” recall period in the EQ-HWB-9 for capturing health fluctuations in dementia. It was found that health fluctuations in dementia were common, with health changes reported in nearly half of all daily health diary assessments. The EQ-HWB-9 dimensions most frequently affected by health fluctuations were exhaustion, sadness/depression, and cognition, changing in more than 65% of cases within seven days. The “7-DAY” recall period reflected a broader range of reported problems and tended to capture more variation in these dimensions, but it also showed lower overall variability in absolute score changes, despite occasional outliers contributing to greater score dispersion. Adherence to the assigned recall period was lower when using the “7-DAY” recall period, especially in PlwD without or with only low health fluctuations, with caregivers explaining that the “7-DAY” recall period was too long. However, adherence to the “7-DAY” recall period was high in PlwD with moderate to high fluctuations. In contrast, adherence to the “TODAY” recall period was highest among those with stable health conditions and low among those with frequent health fluctuations. The findings suggest, that the suitability of a recall period may depend on the extent of health fluctuations. This is consistent with the systematic review by Peasgood et al. [8], which found no universally preferred recall period and indicated that preferences for one-day versus seven-day recall may vary depending on symptom variability.

Health fluctuations in dementia and the use of different administration modes (self vs. proxy)

The high prevalence of health fluctuations observed in our study is consistent with previous research describing dementia as a fluctuation condition characterized by unpredictable day-to-day variations. These are characterized by varying durations of episodes, not only in cognitive dimensions but also in activities of daily living and HRQoL [7, 24–27]. In line with these results, nearly all caregivers in our study reported daily fluctuations in PlwD’s health. The weekly administration of the EQ-HWB-9 confirmed these findings of persistent health changes with changing LSS observed in almost all self- and proxy-ratings, regardless of the recall period used. In a previous study with a similar design [13], day-to-day fluctuations were most commonly associated with changes in mobility, memory, concentration, sleep, and pain/discomfort, as well as usual activities and energy levels. These findings were largely confirmed in the present study.

Beyond the observed health fluctuations, we also identified systematic differences between administration modes (self vs. proxy). Consistent with previous research [11, 28], proxy-ratings were lower than self-ratings, suggesting that caregivers and PlwD may perceive HRQoL differently. This finding further supports the notion that these two raters represent distinct perspectives and should not be considered interchangeable [28]. Taken together, these findings underscore both the high prevalence of health fluctuations in dementia and the challenges in assessing HRQoL in such conditions.

Effects of recall period

In our analysis, the EQ-HWB-9 scores with a 7-day recall period were lower than those obtained by the EQ-HWB-9 with a recall period of today. Bennett et al. [29] also demonstrated the relevance of recall period, although using a different design: They compared a 7-day retrospective assessment with repeated daily assessments covering the same period and found the 7-day recall to be most concordant with the mean of the daily reports. Our study did not include repeated daily EQ-HWB-9 assessments. Therefore the lower 7-DAY scores observed should not be interpreted in terms of greater or lower accuracy, but rather indicate the temporal frame of assessment may influence the outcome.

Importantly, when examining the observed changes from week to week in EQ-HWB-9 LSS, the mean absolute changes and variance of these changes tended to be lower when the 7-DAY recall period was used, even though this recall period was associated with the occurrence of outliers. The longer recall period, compared with the recall period used today, may capture good or bad days and important health events from the past week, which could result in a health state that differs from the one in the today recall frame. Therefore, the 7-DAY recall period may provide a broader representation of health experiences occurring over the previous week, whereas the “TODAY” recall period may be more closely linked to the individual`s current health state. Given these different temporal perspectives, our findings do not support one recall period as generally preferable but emphasize that its selection and interpretation should consider the characteristics of the condition being assessed. This is consistent with Norquist et al. [30], who emphasized that no recall period is universally optimal and that selection should depend on the concept being measured, disease characteristics, and the intended use of the measure. More recently, Xu et al. [31] compared TODAY (EQ-5D-5L) and LAST WEEK (EQ-HWB-9) recall periods and found small differences in measurement properties. The LAST WEEK version generally captured more reported problems and showed greater informativity, suggesting that recall period choice may influence how health and wellbeing are captured. However, capturing experiences over a longer time frame, may also increase susceptibility to recall bias. This interpretation is consistent with findings from other disease areas. For example Rydén et al. [32], who compared repeated daily symptom reports (RESQ-eD) with a retrospective weekly assessment (RESQ-7) covering the same period in patients with Gastroesophageal Reflux Disease, found that patients slightly overestimated symptom intensity and markedly underestimated symptom frequency on weekly recall. Although their study design differs from ours, these findings illustrate how retrospective integration over a longer recall period may influence reported outcomes.

Recall period adherence

Regarding adherence to the assigned recall period, most caregivers followed the instructions. However, adherence to the 7-DAY recall period was lower among caregivers of PlwD with no or low health fluctuations. In contrast, adherence to the 7-DAY recall period was higher among caregivers of PlwD experiencing moderate to high levels of health fluctuations. Recent findings by Ng et al. [33] similarly demonstrate that caregivers may not consistently restrict their responses to the specified 7-day recall period and may draw on experiences outside the requested time frame when evaluating the health and wellbeing of PlwD. These suggest that the suitability of a recall period may depend on the fluctuation profile of the individual and support previous research indicating that recall period selection should consider factors such as the purpose of the assessment, its intended use, and the variability of the health condition [34]. Furthermore, future studies may benefit from implementing a clear instructions of the measures purpose to improve participants’ understanding of the assigned recall period [34]. Therefore, recall period selection may involve a trade-off between capturing health experiences over the intended time frame and respondents’ ability to adhere to the assigned recall period, which should be considered when interpreting patient-reported outcomes in clinical and research settings.

Implications for outcome assessment

Given the challenges associated with selecting an adequate recall period, alternative assessment approaches may warrant consideration. Conducting multiple assessments on consecutive days, using a recall period of today or a weekly basis with a 7-day recall period, so-called momentary data assessments, may be a potential option for more accurately measuring intervention effects when health fluctuates. Blome et al. [35] developed an ambulatory assessment version of the EQ-5D-5L, in which patients with multiple sclerosis rated their health numerous times per day on mobile phones over several days. Patients recommended such daily ambulatory assessments over seven days to assess their own HRQoL most appropriately, which underlines that HRQoL could be measured more accurately in fluctuating health conditions using multiple (ambulatory) assessments. Other studies implemented such strategies in other diseases, such as in rare movement disorders [36]. Future research should examine whether such approaches provide additional information compared with single assessments using longer recall periods, particularly in populations characterized by fluctuating health.

Our findings indicate that recall period selection should be considered in relation to assessment frequency and the expected fluctuation patterns of the target population, as these factors may influence the interpretation of HRQoL outcomes. Although existing recommendations on recall period selection have largely been derived from self-reported outcomes [30, 37], our results suggest these considerations may also apply to proxy-reported HRQoL measures in dementia research. Furthermore, the interpretation of proxy-reported outcomes may also depend on the observability of the assessed health domain. While domains such as mobility and daily activities are more directly observable, subjective experiences such as loneliness, anxiety or sadness may require greater interpretation by caregivers (non-verbal signs) [38, 39]. Building on this, future research should explore hybrid models that combine periodic short-recall assessments with occasional longer-term reflections to balance feasibility and accuracy.

Limitations

The generalizability of the study findings is limited by several aspects. First, the study design may have influenced the recall behaviour. We did not collect repeated daily EQ-HWB-9 assessments. Therefore, the 7-DAY assessments could not be directly compared with corresponding daily reports covering the same period, limiting conclusions about whether observed differences between recall periods reflect recall effects. We also did not set a recall period as a gold standard to compare it with the other recall period. The missing gold standard can limit conclusions about accuracy, though the study provides evidence on the comparability of recall periods and the implications of recall period selection for outcome assessment. In addition, the intensive daily diary documentation and repeated emphasis on day-to-day health changes could have heightened caregivers’ awareness of fluctuations and encouraged a focus on the current health state. This may have affected adherence to the assigned recall period and potentially led to underestimating non-adherence. Moreover, recall-period adherence was assessed using a study-specific, non-validated question. Although this approach provided insights into how caregivers perceived their application of the assigned recall period, it did not allow us to verify whether they correctly understood or consistently applied the intended time frame. In particular, caregivers may have unintentionally included experiences outside the specified recall period without realizing the deviation. Consequently, the reported adherence rates may overestimate actual adherence and should be interpreted with caution. Furthermore, adherence to the recall periods was assessed only among caregivers, resulting in a one-sided perspective that did not capture views of PlwD. Moreover, repeated questionnaire completion may have introduced a learning effect, potentially influencing how participants interpreted and responded to subsequent assessments. The relatively small sample size (N = 74 dyads) limits statistical power. While sufficient to describe health fluctuations, the study was underpowered to detect statistically significant differences between recall groups, particularly regarding score variability. Furthermore, the accuracy of proxy reports may be influenced by the intensity of care provision and the caregiver’s familiarity with the PlwD. However, information on the amount of time spent providing care was not collected in the present study. Our sample included individuals with different dementia subtypes; however, the specific diagnoses were not documented. As patterns of health fluctuations may vary across dementia types and are reported to be more pronounced in Lewy body dementia than in Alzheimer’s disease, we were unable to examine subtype-specific differences. Future studies with larger and diagnostically well-characterized samples are needed to investigate variation in health fluctuations across dementia subtypes. Moreover, an objective clinical assessment of dementia severity was not included in the study. Therefore, the potential influence of disease severity on recall period adherence and HRQoL self and proxy reporting could not be evaluated. Finally, it is not exactly evident to what extent the changes in EQ-HWB-9 scores are caused by random variation instead of manifest health fluctuations. It is essential to ensure that a measure reliably reflects an individual’s health rating, even in the presence of health fluctuations. The EQ-HWB-9 demonstrated satisfactory psychometric performance in previous studies with caregivers [21]. Nevertheless, no additional well-being measure was included in our study, limiting the measures performance in our sample.

Conclusion

This study provides novel insights into the suitability of two different recall periods (Today vs. 7 Day) when assessing HRQoL in PlwD experiencing recurrent health fluctuations. The findings suggest that recall period preferences and adherence may differ according to an individual’s fluctuation profile, indicating that a single recall approach may not be optimal for all PlwD. These results highlight the importance of considering symptom variability when selecting HRQoL assessment strategies in dementia research. More flexible and context-sensitive approaches may improve the validity of patient-reported outcomes and the accurate representation of patient experiences. Future research should investigate these findings in larger and more diverse samples and explore alternative assessment approaches capable of capturing dynamic changes in health status over time.

Supplementary Information

Below is the link to the electronic supplementary material.

References

1.Mainland BJ Herrmann N Mallya S Fiocco AJ Sin GL Shulman KI Ornstein TJ Cognitive fluctuations and cognitive test performance among institutionalized persons with dementia American Journal of Alzheimer's Disease & Other Dementias 2017 32 7 393 400 10.1177/1533317517718954 PMC10852930 28705013 Mainland, B. J., Herrmann, N., Mallya, S., Fiocco, A. J., Sin, G. L., Shulman, K. I., & Ornstein, T. J. (2017). Cognitive Fluctuations and Cognitive Test Performance Among Institutionalized Persons With Dementia. American Journal of Alzheimer's Disease & Other Dementias, 32(7), 393–400. 10.1177/1533317517718954 PMC10852930 28705013

2.Trachsel M Hermann H Biller-Andorno N Cognitive fluctuations as a challenge for the assessment of decision-making capacity in patients with dementia American Journal of Alzheimer's Disease & Other Dementias 2015 30 4 360 363 10.1177/1533317514539377 PMC10852664 24946784 Trachsel, M., Hermann, H., & Biller-Andorno, N. (2015). Cognitive fluctuations as a challenge for the assessment of decision-making capacity in patients with dementia. American Journal of Alzheimer's Disease & Other Dementias, 30(4), 360–363. 10.1177/1533317514539377 PMC10852664 24946784

3.Lee DR Taylor JP Thomas AJ Assessment of cognitive fluctuation in dementia: A systematic review of the literature International Journal Of Geriatric Psychiatry 2012 27 10 989 998 10.1002/gps.2823 22278997 Lee, D. R., Taylor, J. P., & Thomas, A. J. (2012). Assessment of cognitive fluctuation in dementia: A systematic review of the literature. International Journal Of Geriatric Psychiatry, 27(10), 989–998. 10.1002/gps.2823 22278997

4.Rockwood K Fay S Hamilton L Ross E Moorhouse P Good days and bad days in dementia: A qualitative chart review of variable symptom expression International Psychogeriatrics 2014 26 8 1239 1246 10.1017/S1041610214000222 24565377 Rockwood, K., Fay, S., Hamilton, L., Ross, E., & Moorhouse, P. (2014). Good days and bad days in dementia: A qualitative chart review of variable symptom expression. International Psychogeriatrics, 26(8), 1239–1246. 10.1017/S1041610214000222 24565377

5.Webber, T. A., Lorkiewicz, S. A., Kiselica, A. M., & Woods, S. P. (2023). Ecological validity of cognitive fluctuations in dementia with Lewy bodies. Journal Of The International Neuropsychological Society, 1–12. 10.1017/S1355617723000255 PMC10576013 37057867

6.Matar E Shine JM Halliday GM Lewis SJG Cognitive fluctuations in Lewy body dementia: Towards a pathophysiological framework Brain 2020 143 1 31 46 10.1093/brain/awz311 31612904 Matar, E., Shine, J. M., Halliday, G. M., & Lewis, S. J. G. (2020). Cognitive fluctuations in Lewy body dementia: Towards a pathophysiological framework. Brain, 143(1), 31–46. 10.1093/brain/awz311 31612904

7.Sun M Mainland BJ Ornstein TJ Mallya S Fiocco AJ Sin GL Shulman KI Herrmann N The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia International Journal Of Geriatric Psychiatry 2018 33 2 e280 e 10.1002/gps.4788 28940504 Sun, M., Mainland, B. J., Ornstein, T. J., Mallya, S., Fiocco, A. J., Sin, G. L., Shulman, K. I., & Herrmann, N. (2018). The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia. International Journal Of Geriatric Psychiatry, 33(2), e280–e. 10.1002/gps.4788 28940504

8.Peasgood T Caruana JM Mukuria C Systematic review of the effect of a one-day versus seven-day recall duration on patient reported outcome measures (PROMs) Patient 2023 16 3 201 221 10.1007/s40271-022-00611-w 36786931 PMC10121527 Peasgood, T., Caruana, J. M., & Mukuria, C. (2023). Systematic review of the effect of a one-day versus seven-day recall duration on patient reported outcome measures (PROMs). Patient, 16(3), 201–221. 10.1007/s40271-022-00611-w PMC10121527 36786931

9.Herdman M Gudex C Lloyd A Janssen M Kind P Parkin D Bonsel G Badia X Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Quality Of Life Research 2011 20 10 1727 1736 10.1007/s11136-011-9903-x 21479777 PMC3220807 Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality Of Life Research, 20(10), 1727–1736. 10.1007/s11136-011-9903-x PMC3220807 21479777

10.Hounsome N Orrell M Edwards RT EQ-5D as a quality of life measure in people with dementia and their carers: Evidence and key issues Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2011 14 2 390 399 10.1016/j.jval.2010.08.002 21402307 Hounsome, N., Orrell, M., & Edwards, R. T. (2011). EQ-5D as a quality of life measure in people with dementia and their carers: Evidence and key issues. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 14(2), 390–399. 10.1016/j.jval.2010.08.002 21402307

11.Orgeta V Edwards RT Hounsome B Orrell M Woods B The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers Quality Of Life Research 2015 24 2 315 324 10.1007/s11136-014-0770-0 25129054 PMC4317511 Orgeta, V., Edwards, R. T., Hounsome, B., Orrell, M., & Woods, B. (2015). The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers. Quality Of Life Research, 24(2), 315–324. 10.1007/s11136-014-0770-0 PMC4317511 25129054

12.Michalowsky B Xie F Kohlmann T Graske J Wubbeler M Thyrian JR Hoffmann W Acceptability and validity of the EQ-5D in patients living with dementia Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2020 23 6 760 767 10.1016/j.jval.2020.01.022 32540234 Michalowsky, B., Xie, F., Kohlmann, T., Graske, J., Wubbeler, M., Thyrian, J. R., & Hoffmann, W. (2020). Acceptability and validity of the EQ-5D in patients living with dementia. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 23(6), 760–767. 10.1016/j.jval.2020.01.022 32540234

13.Michalowsky B Hoffmann W Xie F Psychometric properties of EQ-5D-3L and EQ-5D-5L in cognitively impaired patients living with dementia Journal Of Alzheimer’S Disease 2021 83 1 77 87 10.3233/JAD-210421 34275901 Michalowsky, B., Hoffmann, W., & Xie, F. (2021). Psychometric properties of EQ-5D-3L and EQ-5D-5L in cognitively impaired patients living with dementia. Journal Of Alzheimer’S Disease, 83(1), 77–87. 10.3233/JAD-210421 34275901

14.Michalowsky B Engel L Buchholz M Weber N Kohlmann T Xie F Health fluctuations in dementia and its impact on the assessment of health-related quality of life using the EQ-5D-5L Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2024 27 8 1092 1099 10.1016/j.jval.2024.04.010 38649092 Michalowsky, B., Engel, L., Buchholz, M., Weber, N., Kohlmann, T., & Xie, F. (2024). Health fluctuations in dementia and its impact on the assessment of health-related quality of life using the EQ-5D-5L. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 27(8), 1092–1099. 10.1016/j.jval.2024.04.010 38649092

15.Kalbe E Kessler J Calabrese P Smith R Passmore AP Brand M Bullock R DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia International Journal Of Geriatric Psychiatry 2004 19 2 136 143 10.1002/gps.1042 14758579 Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A. P., Brand, M., & Bullock, R. (2004). DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal Of Geriatric Psychiatry, 19(2), 136–143. 10.1002/gps.1042 14758579

16.Salis, F., Costaggiu, D., & Mandas, A. (2023). Mini-mental state examination: Optimal cut-off levels for mild and severe cognitive impairment. Geriatrics (Basel), 8(1). 10.3390/geriatrics8010012 PMC9844353 36648917

17.Folstein MF Robins LN Helzer JE The mini-mental state examination Archives Of General Psychiatry 1983 40 7 812 10.1001/archpsyc.1983.01790060110016 6860082 Folstein, M. F., Robins, L. N., & Helzer, J. E. (1983). The mini-mental state examination. Archives Of General Psychiatry, 40(7), 812. 10.1001/archpsyc.1983.01790060110016 6860082

18.Branez-Condorena A Soriano-Moreno DR Navarro-Flores A Solis-Chimoy B Diaz-Barrera ME Taype-Rondan A Accuracy of the geriatric depression scale (GDS)-4 and GDS-5 for the screening of depression among older adults: A systematic review and meta-analysis PLoS One 2021 16 7 e0253899 10.1371/journal.pone.0253899 34197527 PMC8248624 Branez-Condorena, A., Soriano-Moreno, D. R., Navarro-Flores, A., Solis-Chimoy, B., Diaz-Barrera, M. E., & Taype-Rondan, A. (2021). Accuracy of the geriatric depression scale (GDS)-4 and GDS-5 for the screening of depression among older adults: A systematic review and meta-analysis. PLoS One, 16(7), e0253899. 10.1371/journal.pone.0253899 PMC8248624 34197527

19.Charlson ME Charlson RE Peterson JC Marinopoulos SS Briggs WM Hollenberg JP The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients Journal Of Clinical Epidemiology 2008 61 12 1234 1240 10.1016/j.jclinepi.2008.01.006 18619805 Charlson, M. E., Charlson, R. E., Peterson, J. C., Marinopoulos, S. S., Briggs, W. M., & Hollenberg, J. P. (2008). The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. Journal Of Clinical Epidemiology, 61(12), 1234–1240. 10.1016/j.jclinepi.2008.01.006 18619805

20.Bedard M Molloy DW Squire L Dubois S Lever JA O’Donnell M The Zarit Burden Interview: A new short version and screening version The Gerontologist 2001 41 5 652 657 10.1093/geront/41.5.652 11574710 Bedard, M., Molloy, D. W., Squire, L., Dubois, S., Lever, J. A., & O’Donnell, M. (2001). The Zarit Burden Interview: A new short version and screening version. The Gerontologist, 41(5), 652–657. 10.1093/geront/41.5.652 11574710

21.Bailey C Peasgood T Michalowsky B Engel L The psychometric performance of the EQ-HWB in caregivers of persons living with dementia Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2025 10.1016/j.jval.2025.04.2168 40350057 Bailey, C., Peasgood, T., Michalowsky, B., & Engel, L. (2025). The psychometric performance of the EQ-HWB in caregivers of persons living with dementia. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research. 10.1016/j.jval.2025.04.2168 40350057

22.Bailey C Dalziel K Jones R Hiscock H Devlin NJ Peasgood, and t. Quality of Life in Kids: Key evidence to strengthen decisions in Australia Project, The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions Pharmacoeconomics 2024 42 Suppl 1 163 179 10.1007/s40273-024-01351-5 38238605 PMC11168993 Bailey, C., Dalziel, K., Jones, R., Hiscock, H., & Devlin, N. J. (2024). Peasgood, and t. Quality of Life in Kids: Key evidence to strengthen decisions in Australia Project, The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions. Pharmacoeconomics, 42(Suppl 1), 163–179. 10.1007/s40273-024-01351-5 PMC11168993 38238605

23.Feng YS Kohlmann T Peasgood T Engel L Mulhern B Pickard AS Scoring the EQ-HWB-S: Can we do it without value sets? A non-parametric item response theory analysis Quality Of Life Research 2024 33 5 1211 1222 10.1007/s11136-024-03601-7 38381281 PMC11045574 Feng, Y. S., Kohlmann, T., Peasgood, T., Engel, L., Mulhern, B., & Pickard, A. S. (2024). Scoring the EQ-HWB-S: Can we do it without value sets? A non-parametric item response theory analysis. Quality Of Life Research, 33(5), 1211–1222. 10.1007/s11136-024-03601-7 PMC11045574 38381281

24.Sanghera S Coast J Measuring quality-adjusted life-years when health fluctuates Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2020 23 3 343 350 10.1016/j.jval.2019.09.2753 32197730 Sanghera, S., & Coast, J. (2020). Measuring quality-adjusted life-years when health fluctuates. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 23(3), 343–350. 10.1016/j.jval.2019.09.2753 32197730

25.Pieruccini-Faria F Black SE Masellis M Smith EE Almeida QJ Li KZH Bherer L Camicioli R Montero-Odasso M Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian consortium of neurodegeneration in aging (CCNA) and the gait and brain study Alzheimers Dement 2021 17 8 1317 1328 10.1002/alz.12298 33590967 PMC8451764 Pieruccini-Faria, F., Black, S. E., Masellis, M., Smith, E. E., Almeida, Q. J., Li, K. Z. H., Bherer, L., Camicioli, R., & Montero-Odasso, M. (2021). Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian consortium of neurodegeneration in aging (CCNA) and the gait and brain study. Alzheimers Dement, 17(8), 1317–1328. 10.1002/alz.12298 PMC8451764 33590967

26.Gleason CE Norton D Anderson ED Wahoske M Washington DT Umucu E Koscik RL Dowling NM Johnson SC Carlsson CM Asthana S Alzheimer’s disease neuroimaging, cognitive variability predicts incident Alzheimer’s disease and mild cognitive impairment comparable to a cerebrospinal fluid biomarker Journal Of Alzheimer’S Disease 2018 61 1 79 89 10.3233/JAD-170498 29125485 PMC5714663 Gleason, C. E., Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., Dowling, N. M., Johnson, S. C., Carlsson, C. M., & Asthana, S. (2018). Alzheimer’s disease neuroimaging, cognitive variability predicts incident Alzheimer’s disease and mild cognitive impairment comparable to a cerebrospinal fluid biomarker. Journal Of Alzheimer’S Disease, 61(1), 79–89. 10.3233/JAD-170498 PMC5714663 29125485

27.Fenton L Isenberg AL Aslanyan V Albrecht D Contreras JA Stradford J Monreal T Pa J Variability in objective sleep is associated with Alzheimer’s pathology and cognition Brain Communications 2023 5 2 fcad031 10.1093/braincomms/fcad031 36895954 PMC9989141 Fenton, L., Isenberg, A. L., Aslanyan, V., Albrecht, D., Contreras, J. A., Stradford, J., Monreal, T., & Pa, J. (2023). Variability in objective sleep is associated with Alzheimer’s pathology and cognition. Brain Communications, 5(2), fcad031. 10.1093/braincomms/fcad031 PMC9989141 36895954

28.Buchholz M Engel L Kleinke F Mühlichen F Pfaff M Platen M Rädke A Scharf A Weber N van den Berg N Hoffmann W Michalowsky B Discrepancies between self- and proxy-rated quality of life in people living with dementia Alzheimer's & Dementia: Translational Research & Clinical Interventions 2024 10 2 e12486 10.1002/trc2.12486 PMC11186300 38899046 Buchholz, M., Engel, L., Kleinke, F., Mühlichen, F., Pfaff, M., Platen, M., Rädke, A., Scharf, A., Weber, N., van den Berg, N., Hoffmann, W., & Michalowsky, B. (2024). Discrepancies between self- and proxy-rated quality of life in people living with dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 10(2), e12486. 10.1002/trc2.12486 PMC11186300 38899046

29.Bennett AV Patrick DL Bushnell DM Chiou CF Diehr P Comparison of 7-day and repeated 24-h recall of type 2 diabetes Quality Of Life Research 2011 20 5 769 777 10.1007/s11136-010-9791-5 21088912 Bennett, A. V., Patrick, D. L., Bushnell, D. M., Chiou, C. F., & Diehr, P. (2011). Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality Of Life Research, 20(5), 769–777. 10.1007/s11136-010-9791-5 21088912

30.Norquist JM Girman C Fehnel S DeMuro-Mercon C Santanello N Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration Quality Of Life Research 2012 21 6 1013 1020 10.1007/s11136-011-0003-8 21909804 Norquist, J. M., Girman, C., Fehnel, S., DeMuro-Mercon, C., & Santanello, N. (2012). Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration. Quality Of Life Research, 21(6), 1013–1020. 10.1007/s11136-011-0003-8 21909804

31.Xu RH Yang C Rencz F Exploring recall periods for EQ-5D-5L and EQ-HWB-9: A Hong Kong population study Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2026 29 6 1074 1085 10.1016/j.jval.2026.01.001 41548714 Xu, R. H., Yang, C., & Rencz, F. (2026). Exploring recall periods for EQ-5D-5L and EQ-HWB-9: A Hong Kong population study. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 29(6), 1074–1085. 10.1016/j.jval.2026.01.001 41548714

32.Ryden A Leavy OC Halling K Stone AA Comparison of daily versus weekly recording of gastroesophageal reflux disease symptoms in patients with a partial response to proton pump inhibitor therapy Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research 2016 19 6 829 833 10.1016/j.jval.2016.05.007 27712711 Ryden, A., Leavy, O. C., Halling, K., & Stone, A. A. (2016). Comparison of daily versus weekly recording of gastroesophageal reflux disease symptoms in patients with a partial response to proton pump inhibitor therapy. Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 19(6), 829–833. 10.1016/j.jval.2016.05.007 27712711

33.Ng CA Doherty K Bryan M Carlton J Luckett T Mulhern B Norman R Wills K Roydhouse J Carers’ interpretation of the recall period and perspective-taking when completing the EQ health and wellbeing instrument (EQ-HWB)-9 as proxies for people with dementia: a think-aloud study Quality of Life Research 2026 35 5 115 10.1007/s11136-026-04230-y 41920390 PMC13043530 Ng, C. A., Doherty, K., Bryan, M., Carlton, J., Luckett, T., Mulhern, B., Norman, R., Wills, K., & Roydhouse, J. (2026). Carers’ interpretation of the recall period and perspective-taking when completing the EQ health and wellbeing instrument (EQ-HWB)-9 as proxies for people with dementia: a think-aloud study. Quality of Life Research, 35(5), 115. 10.1007/s11136-026-04230-y PMC13043530 41920390

34.Dagne H Campbell K Saul A Roydhouse J Proxy reporting in health: A scoping review of instructions, perspectives, and reporting experiences Quality Of Life Research 2025 4 7 1835 1847 10.1007/s11136-025-03929-8 PMC12182471 40011354 Dagne, H., Campbell, K., Saul, A., & Roydhouse, J. (2025). Proxy reporting in health: A scoping review of instructions, perspectives, and reporting experiences. Quality Of Life Research, 4(7), 1835–1847. 10.1007/s11136-025-03929-8 PMC12182471 40011354

35.Blome C Carlton J Heesen C Janssen MF Lloyd A Otten M Brazier J How to measure fluctuating impairments in people with MS: Development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study Quality Of Life Research 2021 30 7 2081 2096 10.1007/s11136-021-02802-8 33710593 PMC8233275 Blome, C., Carlton, J., Heesen, C., Janssen, M. F., Lloyd, A., Otten, M., & Brazier, J. (2021). How to measure fluctuating impairments in people with MS: Development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study. Quality Of Life Research, 30(7), 2081–2096. 10.1007/s11136-021-02802-8 PMC8233275 33710593

36.Buchholz, M., Weber, N., Borel, S., Sayah, S., Xie, F., Schulz, J. B., Reetz, K., Boesch, S., Klopstock, T., Karin, I., Schöls, L., Grobe-Einsler, M., Klockgether, T., Davies, E. H., Schmeder, M., Nadke, A., & Michalowsky, B. (2023). Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): Protocol of an observational study using momentary data assessments via mobile health app. BMJ Open, 13(8): p. e10.1136/bmjopen-2023-075736 PMC10394552 37527887

37.Stull, D. E., Leidy, N. K., Parasuraman, B., & Chassany, O. (2009). Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. Current Medical Research And Opinion, 25(4). 10.1185/03007990902774765 . 929 – 42.19257798

38.Buchholz, M., Engel, L., Xie, F., & Michalowsky, B. (2026). Examining the face validity of the EQ-HWB-9 in dementia: Caregiver interpretation across Today and 7-Day recall periods. Health And Quality Of Life Outcomes, 24(1). 10.1186/s12955-026-02478-z PMC12924600 41606591

39.Hutchinson, C., Worley, A., Khadka, J., Milte, R., Cleland, J., & Ratcliffe, J. (2022). Do we agree or disagree? A systematic review of the application of preference-based instruments in self and proxy reporting of quality of life in older people (p. 115046). Social Science & Medicine. 10.1016/j.socscimed.2022.115046 35636050

Come citare questo studio

Maresa Buchholz, Lidia Engel, Feng Xie, Bernhard Michalowsky. (2026). Testing the EQ-HWB-9 with seven-day versus today recall periods in dementia: variability and recall adherence under health fluctuations.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. DOI: 10.1007/s11136-026-04432-4

Consulta la pubblicazione originale ↗